Comparison between Cryogenic OGS IPO and Ikeda IPO.
Cryogenic OGS IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Ikeda IPO is a SME Bookbuilding proposed to list at BSE SME.
| Cryogenic OGS IPO | Ikeda IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Novus Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Cryogenic OGS IPO is up to ₹16.88 Cr whereas the issue size of the Ikeda IPO is up to ₹0.00 Cr. The final issue price of Cryogenic OGS IPO is ₹47.00 per share and of Ikeda IPO is .
| Cryogenic OGS IPO | Ikeda IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹44.00 per share | |
| Issue Price (Upper) | ₹47.00 per share | |
| Issue Price (Final) | ₹47.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 35,91,000 shares | 26,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹16.88 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 10,65,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,91,000 shares | 36,93,600 shares |
| Issue Size Total (Amount) | up to ₹16.88 Cr | up to ₹0.00 Cr |
Cryogenic OGS IPO opens on Jul 03, 2025, while Ikeda IPO opens on . The closing date of Cryogenic OGS IPO and Ikeda IPO is Jul 07, 2025, and , respectively.
| Cryogenic OGS IPO | Ikeda IPO | |
|---|---|---|
| Anchor Bid Date | Jul 02, 2025 | |
| Issue Open | Jul 03, 2025 | |
| Issue Close | Jul 07, 2025 | |
| Basis Of Allotment (Tentative) | Jul 08, 2025 | |
| Initiation of Refunds (Tentative) | Jul 09, 2025 | |
| Credit of Share (Tentative) | Jul 09, 2025 | |
| Listing date (Tentative) | Jul 10, 2025 | |
| Anchor Lockin End date 1 | Aug 06, 2025 | |
| Anchor Lockin End date 2 | Oct 05, 2025 |
Cryogenic OGS IPO P/E ratio is 8.06, as compared to Ikeda IPO P/E ratio of .
| Cryogenic OGS IPO | Ikeda IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Cryogenic OGS Ltd.'s revenue increased by 32% and profit after tax (PAT) rose by 15% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 54.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹67.12 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.62 | 34.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28.93 | 27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.12 | 31.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Cryogenic OGS IPO Retail Individual Investors (RII) are offered 12,60,000 shares while in Ikeda IPO retail investors are offered 12,60,000 shares. Qualified Institutional Buyers (QIB) are offered 7,17,000 shares in Cryogenic OGS IPO and in Ikeda IPO.
| Cryogenic OGS IPO | Ikeda IPO | |
|---|---|---|
| Anchor Investor Reservation | 10,74,000 shares | |
| Market Maker Reservation | 1,89,000 shares | |
| QIB | 7,17,000 shares | |
| NII | 5,40,000 shares | |
| RII | 12,60,000 shares | |
| Employee | ||
| Others | ||
| Total | 35,91,000 shares |
Cryogenic OGS IPO subscribed 487.07x in total, whereas Ikeda IPO subscribed .
| Cryogenic OGS IPO | Ikeda IPO | |
|---|---|---|
| QIB (times) | 209.59x | |
| NII (times) | 1,155.38x | |
| Big NII (times) | 0.00x | |
| Small NII (times) | 0.00x | |
| RII (times) | 773.70x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 487.07x |
